- Visibility 713 Views
- Downloads 627 Downloads
- Permissions
- DOI 10.18231/j.ijogr.v.12.i.3.9
-
CrossMark
The role of salivary uric acid as predictive marker for preeclampsia in comparison with serum uric acid
- Author Details:
-
Sarah Ismael
-
Shatha Sami Hussein *
-
Manal Madany Abdulqader
Sarah Ismael
Shatha Sami Hussein *
Background: Pregnancy may be complicated by many medical disease which convert the pregnancy to high risk one, many effort try to decrease the complication by early detection once, and by safe non invasive test another.
Aim & Objective: To evaluate the role of salivary uric acid in PET versus normal pregnancy in comparison with serum uric acid.
Materials and Methods: The study involved 180 patient divided into three group 60 patient healthy not pregnant women as control, 1st study group (A) 60 normotensive pregnant women in third trimester, 2nd study group (B) 60 patient diagnosed as PET both group in their third trimester of pregnancy, uric acid levels in both the serum & saliva was recorded by ELISA and the result was compared statistically. A cross-sectional study performed at AlYarmouk Teaching Hospital from October 2022 to October 2023.
Result: The result show when compare serum and salivary uric acid level in the three studying groups the mean of serum uric acid level were46.65±6.76mg/dl, 50.03±6.28mg/dl, 63.31±3.61 mg/dl in the non pregnant,pregnant,pregnant with PET consequently with obvious difference P-value 0.0001. Salivary uric acid was significantly increased in the pregnant PET group mean level was (50.59-83.58mg/dl) in comparison with (33.95-63.11mg/dl)in non pregnant and (38.94-66.93mg/dl) in pregnant group were the p- value 0.0001
Conclusion: Salivary UA can be used as a simple non invasive test to monitor women with preeclampsia.
References
- Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018 Jul;72(1):24–43.
- Kattah A. Preeclampsia and Kidney Disease: Deciphering Cause and Effect. Curr Hypertens Rep. 2020;22(11):91.
- Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020 Jun;135(6):e237–e60.
- Hao J, Hassen D, Hao Q, Graham J, Paglia MJ, Brown J, et al. Maternal and Infant Health Care Costs Related to Preeclampsia. Obstet Gynecol. 2019;134(6):1227–33.
- Boeldt DS, Bird IM. Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J Endocrinol. 2017;232(1):R27–R44.
- Nakagawa T, Kang D-H, Johnson RJ. An elevation in serum uric acid precedes the development of preeclampsia. Hypertens Res. 2023;46(3):809–11.
- Taravati A, Tohidi F. Comprehensive analysis of oxidative stress markers and antioxidants status in preeclampsia. Taiwan J Obstet Gynecol. 2018;57(6):779–90.
- Martínez-Gascón L, Martínez-Uriarte J, Gutierrez I, López Soto Á, Romualdo L, Albaladejo-Otón M, et al. Intervalos de referencia de ácido úrico en suero durante la gestación. Rev Lab Clin. 2016;9(2):35–9.
- Amini E, Sheikh M, Hantoushzadeh S, Shariat M, Abdollahi A, Kashanian M. Maternal hyperuricemia in normotensive singleton pregnancy, a prenatal finding with continuous perinatal and postnatal effects, a prospective cohort study. BMC Pregnancy Childbirth. 2014;14:104.
- Ryu A, Cho NJ, Kim YS, Lee EY. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Medicine (Baltimore). 2019;98(18):e15462.
- Khaliq OP, Konoshita T, Moodley J, Naicker T. The Role of Uric Acid in Preeclampsia: Is Uric Acid a Causative Factor or a Sign of Preeclampsia? Curr Hypertens Rep. 2018;20:80. 414 Ismael et al. / Indian Journal of Obstetrics and Gynecology Research 2025;12(3):409–414
- Corominas AI, Balconi SM, Palermo M, Maskin B, Damiano AE. [Serum uric acid levels and risk of developing preeclampsia]. Medicina (B Aires). 2014;74(6):462–71.
- Masoura S, Makedou K, Theodoridis T, Kourtis A, Zepiridis L, Athanasiadis A, et al. The involvement of uric acid in the pathogenesis of preeclampsia. Curr Hypertens Rev. 2015;11(2):110–5.
- Shirasuna K, Karasawa T, Takahashi M. Role of the NLRP3 Inflammasome in Preeclampsia. Front Endocrinol (Lausanne). 2020;11:80.
- Soukup M, Biesiada I, Henderson A, Idowu B, Rodeback D, Ridpath L, et al. Salivary uric acid as a noninvasive biomarker of metabolic syndrome. Diabetol Metab Syndr. 2012;4(1):14.
- Hadi BA, Al-jubouri RH. Salivary and plasma analysis of oxidative stress biomarkers in end stage renal failure patients. J Bagh Coll Dent. 2011;23(2):46–50.
- Sangeeta N, Shaini L, Basar G, Devi S, Chhuangi V, Mandal KK, et al. Serum Uric Acid and Homocysteine as Predictors of Pre- eclampsia. J Diabetes Metab. 2013;4(4):259.
- Tejal P, Astha D. Relationship of serum uric acid level to maternal and perinatal outcome in patients with hypertensive disorders of pregnancy. Gujarat Med J. 2014;69(2):45–7.
- Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta. 2008;29 Suppl A:S67–72.